It's nicely comprehended that IL-2 is really a pleiotropic cytokine positioned at the crossroads of T mobile activation and regulation. As such, it can be critical to engineer an IL-2 molecule that is definitely biased to effector cells bearing the intermediate affinity receptor, for example naïve and memory CD8+ T cells and NK cells, as opposed t